Tag: NTI drugs
-
FDA Bioequivalence Standards for NTI Drugs: Special Requirements Explained
Explore the FDA's strict bioequivalence standards for Narrow Therapeutic Index (NTI) drugs. Learn about the 90-111% limits, RSABE methodology, and why these rules matter for patient safety.
-
Combination NTI Drugs and Generic Availability: Coverage and Gaps
Combination NTI drugs offer life-saving treatment for complex conditions, but generic versions are nearly nonexistent due to strict bioequivalence requirements. This gap creates real risks for patients and healthcare systems.